Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma
For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N). R...
Gespeichert in:
Veröffentlicht in: | Cancer 2024-02, Vol.130 (3), p.410-420 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 420 |
---|---|
container_issue | 3 |
container_start_page | 410 |
container_title | Cancer |
container_volume | 130 |
creator | de Almeida, John R Su, Jie Susie Kolarski, Mirko Manojlovic Truong, Tra Weinreb, Ilan Perez-Ordonez, Bayardo Smith, Stephen M Hosni, Ali Patel, Snehal Valero, Cristina Xu, Bin Ghossein, Ronald Katabi, Nora Clark, Jonathan Low, Tsu-Hui Hubert Gupta, Ruta Graboyes, Evan M Davies, Joel Richardson, Mary Pasham, Vishu Jester, Rachel Goldstein, David P Huang, Shao Hui Xu, Wei O'Sullivan, Brian |
description | For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N).
Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals.
A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold.
A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size. |
doi_str_mv | 10.1002/cncr.35020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2869221791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920610732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</originalsourceid><addsrcrecordid>eNpdkV9LwzAUxYMobk5f_AAS8EWEzpukbZpHmX9hzpcJvpU0TUdGm2xJO9i3t3NzDz5d7rk_Dod7ELomMCYA9EFZ5ccsAQonaEhA8AhITE_REACyKInZ9wBdhLDsV04Tdo4GjPOEkAyGyDzpja7dqtG2xdKWeCNrU8rWOItdhSW2rr_j-ewDh1YujF3gWaRqGYKpjDpyzssaK7kx7RaHdScb1wWsdL0TvTLWNfISnVWyDvrqMEfo6-V5PnmLpp-v75PHaaQYSdqICRCFljwpi1RBGpcJ0WUcq0xpUFywKlW9pojgDATjCa8ynWVFqXWRQswZG6G7ve_Ku3WnQ5s3JuyiSKv7VDnNUkEp4YL06O0_dOk6b_t0ORUUUgKc0Z6631PKuxC8rvKVN43025xAvisg3xWQ_xbQwzcHy65odHlE_z7OfgAoJoEU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920610732</pqid></control><display><type>article</type><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><source>Wiley Free Content</source><source>Wiley Online Library - AutoHoldings Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</creator><creatorcontrib>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</creatorcontrib><description>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N).
Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals.
A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold.
A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.35020</identifier><identifier>PMID: 37751180</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer ; Classification ; Lymph nodes ; Oral cancer ; Oral carcinoma ; Oral cavity ; Squamous cell carcinoma</subject><ispartof>Cancer, 2024-02, Vol.130 (3), p.410-420</ispartof><rights>2023 American Cancer Society.</rights><rights>2024 American Cancer Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</citedby><cites>FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</cites><orcidid>0000-0002-1546-5033 ; 0000-0003-3397-2888 ; 0000-0003-4638-9835 ; 0000-0003-3766-468X ; 0000-0001-9775-5132</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37751180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Almeida, John R</creatorcontrib><creatorcontrib>Su, Jie Susie</creatorcontrib><creatorcontrib>Kolarski, Mirko Manojlovic</creatorcontrib><creatorcontrib>Truong, Tra</creatorcontrib><creatorcontrib>Weinreb, Ilan</creatorcontrib><creatorcontrib>Perez-Ordonez, Bayardo</creatorcontrib><creatorcontrib>Smith, Stephen M</creatorcontrib><creatorcontrib>Hosni, Ali</creatorcontrib><creatorcontrib>Patel, Snehal</creatorcontrib><creatorcontrib>Valero, Cristina</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Ghossein, Ronald</creatorcontrib><creatorcontrib>Katabi, Nora</creatorcontrib><creatorcontrib>Clark, Jonathan</creatorcontrib><creatorcontrib>Low, Tsu-Hui Hubert</creatorcontrib><creatorcontrib>Gupta, Ruta</creatorcontrib><creatorcontrib>Graboyes, Evan M</creatorcontrib><creatorcontrib>Davies, Joel</creatorcontrib><creatorcontrib>Richardson, Mary</creatorcontrib><creatorcontrib>Pasham, Vishu</creatorcontrib><creatorcontrib>Jester, Rachel</creatorcontrib><creatorcontrib>Goldstein, David P</creatorcontrib><creatorcontrib>Huang, Shao Hui</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>O'Sullivan, Brian</creatorcontrib><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><title>Cancer</title><addtitle>Cancer</addtitle><description>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N).
Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals.
A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold.
A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</description><subject>Cancer</subject><subject>Classification</subject><subject>Lymph nodes</subject><subject>Oral cancer</subject><subject>Oral carcinoma</subject><subject>Oral cavity</subject><subject>Squamous cell carcinoma</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkV9LwzAUxYMobk5f_AAS8EWEzpukbZpHmX9hzpcJvpU0TUdGm2xJO9i3t3NzDz5d7rk_Dod7ELomMCYA9EFZ5ccsAQonaEhA8AhITE_REACyKInZ9wBdhLDsV04Tdo4GjPOEkAyGyDzpja7dqtG2xdKWeCNrU8rWOItdhSW2rr_j-ewDh1YujF3gWaRqGYKpjDpyzssaK7kx7RaHdScb1wWsdL0TvTLWNfISnVWyDvrqMEfo6-V5PnmLpp-v75PHaaQYSdqICRCFljwpi1RBGpcJ0WUcq0xpUFywKlW9pojgDATjCa8ynWVFqXWRQswZG6G7ve_Ku3WnQ5s3JuyiSKv7VDnNUkEp4YL06O0_dOk6b_t0ORUUUgKc0Z6631PKuxC8rvKVN43025xAvisg3xWQ_xbQwzcHy65odHlE_z7OfgAoJoEU</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>de Almeida, John R</creator><creator>Su, Jie Susie</creator><creator>Kolarski, Mirko Manojlovic</creator><creator>Truong, Tra</creator><creator>Weinreb, Ilan</creator><creator>Perez-Ordonez, Bayardo</creator><creator>Smith, Stephen M</creator><creator>Hosni, Ali</creator><creator>Patel, Snehal</creator><creator>Valero, Cristina</creator><creator>Xu, Bin</creator><creator>Ghossein, Ronald</creator><creator>Katabi, Nora</creator><creator>Clark, Jonathan</creator><creator>Low, Tsu-Hui Hubert</creator><creator>Gupta, Ruta</creator><creator>Graboyes, Evan M</creator><creator>Davies, Joel</creator><creator>Richardson, Mary</creator><creator>Pasham, Vishu</creator><creator>Jester, Rachel</creator><creator>Goldstein, David P</creator><creator>Huang, Shao Hui</creator><creator>Xu, Wei</creator><creator>O'Sullivan, Brian</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1546-5033</orcidid><orcidid>https://orcid.org/0000-0003-3397-2888</orcidid><orcidid>https://orcid.org/0000-0003-4638-9835</orcidid><orcidid>https://orcid.org/0000-0003-3766-468X</orcidid><orcidid>https://orcid.org/0000-0001-9775-5132</orcidid></search><sort><creationdate>20240201</creationdate><title>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</title><author>de Almeida, John R ; Su, Jie Susie ; Kolarski, Mirko Manojlovic ; Truong, Tra ; Weinreb, Ilan ; Perez-Ordonez, Bayardo ; Smith, Stephen M ; Hosni, Ali ; Patel, Snehal ; Valero, Cristina ; Xu, Bin ; Ghossein, Ronald ; Katabi, Nora ; Clark, Jonathan ; Low, Tsu-Hui Hubert ; Gupta, Ruta ; Graboyes, Evan M ; Davies, Joel ; Richardson, Mary ; Pasham, Vishu ; Jester, Rachel ; Goldstein, David P ; Huang, Shao Hui ; Xu, Wei ; O'Sullivan, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-3909bea75db6c064d51ed44c8ce0c793f6c4d5c1973093757f8e88bdeeb604733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer</topic><topic>Classification</topic><topic>Lymph nodes</topic><topic>Oral cancer</topic><topic>Oral carcinoma</topic><topic>Oral cavity</topic><topic>Squamous cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Almeida, John R</creatorcontrib><creatorcontrib>Su, Jie Susie</creatorcontrib><creatorcontrib>Kolarski, Mirko Manojlovic</creatorcontrib><creatorcontrib>Truong, Tra</creatorcontrib><creatorcontrib>Weinreb, Ilan</creatorcontrib><creatorcontrib>Perez-Ordonez, Bayardo</creatorcontrib><creatorcontrib>Smith, Stephen M</creatorcontrib><creatorcontrib>Hosni, Ali</creatorcontrib><creatorcontrib>Patel, Snehal</creatorcontrib><creatorcontrib>Valero, Cristina</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Ghossein, Ronald</creatorcontrib><creatorcontrib>Katabi, Nora</creatorcontrib><creatorcontrib>Clark, Jonathan</creatorcontrib><creatorcontrib>Low, Tsu-Hui Hubert</creatorcontrib><creatorcontrib>Gupta, Ruta</creatorcontrib><creatorcontrib>Graboyes, Evan M</creatorcontrib><creatorcontrib>Davies, Joel</creatorcontrib><creatorcontrib>Richardson, Mary</creatorcontrib><creatorcontrib>Pasham, Vishu</creatorcontrib><creatorcontrib>Jester, Rachel</creatorcontrib><creatorcontrib>Goldstein, David P</creatorcontrib><creatorcontrib>Huang, Shao Hui</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>O'Sullivan, Brian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Almeida, John R</au><au>Su, Jie Susie</au><au>Kolarski, Mirko Manojlovic</au><au>Truong, Tra</au><au>Weinreb, Ilan</au><au>Perez-Ordonez, Bayardo</au><au>Smith, Stephen M</au><au>Hosni, Ali</au><au>Patel, Snehal</au><au>Valero, Cristina</au><au>Xu, Bin</au><au>Ghossein, Ronald</au><au>Katabi, Nora</au><au>Clark, Jonathan</au><au>Low, Tsu-Hui Hubert</au><au>Gupta, Ruta</au><au>Graboyes, Evan M</au><au>Davies, Joel</au><au>Richardson, Mary</au><au>Pasham, Vishu</au><au>Jester, Rachel</au><au>Goldstein, David P</au><au>Huang, Shao Hui</au><au>Xu, Wei</au><au>O'Sullivan, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>130</volume><issue>3</issue><spage>410</spage><epage>420</epage><pages>410-420</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N-classification (TNM-8-N).
Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N-classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM-8-N and two published proposals.
A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44-2.55] and 3.21 [95% CI, 2.44-4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44-2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05-1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81-1.36]). The aHR proposal provided optimal performance with these changes to TNM-8-N: 1) stratification of ENE extent, 2) elimination of N2c and 6-cm threshold, and 3) stratification of N2b by 3 cm threshold.
A new N-classification improved staging performance compared to TNM-8-N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37751180</pmid><doi>10.1002/cncr.35020</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1546-5033</orcidid><orcidid>https://orcid.org/0000-0003-3397-2888</orcidid><orcidid>https://orcid.org/0000-0003-4638-9835</orcidid><orcidid>https://orcid.org/0000-0003-3766-468X</orcidid><orcidid>https://orcid.org/0000-0001-9775-5132</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2024-02, Vol.130 (3), p.410-420 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_2869221791 |
source | Wiley Free Content; Wiley Online Library - AutoHoldings Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Cancer Classification Lymph nodes Oral cancer Oral carcinoma Oral cavity Squamous cell carcinoma |
title | Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T07%3A26%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20novel%20TNM%20staging%20N-classification%20of%20oral%20cavity%20squamous%20cell%20carcinoma&rft.jtitle=Cancer&rft.au=de%20Almeida,%20John%20R&rft.date=2024-02-01&rft.volume=130&rft.issue=3&rft.spage=410&rft.epage=420&rft.pages=410-420&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.35020&rft_dat=%3Cproquest_cross%3E2920610732%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920610732&rft_id=info:pmid/37751180&rfr_iscdi=true |